315 related articles for article (PubMed ID: 17979860)
21. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy.
Moore AP; Ade-Hall RA; Smith CT; Rosenbloom L; Walsh HP; Mohamed K; Williamson PR
Neurology; 2008 Jul; 71(2):122-8. PubMed ID: 18606966
[TBL] [Abstract][Full Text] [Related]
22. Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study.
Mall V; Heinen F; Siebel A; Bertram C; Hafkemeyer U; Wissel J; Berweck S; Haverkamp F; Nass G; Döderlein L; Breitbach-Faller N; Schulte-Mattler W; Korinthenberg R
Dev Med Child Neurol; 2006 Jan; 48(1):10-3. PubMed ID: 16359588
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of a child-friendly form of constraint-induced movement therapy in hemiplegic cerebral palsy: a randomized control trial.
Charles JR; Wolf SL; Schneider JA; Gordon AM
Dev Med Child Neurol; 2006 Aug; 48(8):635-42. PubMed ID: 16836774
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children.
Zier JL; Rivard PF; Krach LE; Wendorf HR
Dev Med Child Neurol; 2008 Nov; 50(11):854-8. PubMed ID: 19046178
[TBL] [Abstract][Full Text] [Related]
25. [Botulinum toxin type A in the treatment plan for cerebral palsy].
Strobl W
Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
Lundy CT; Doherty GM; Fairhurst CB
Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
[TBL] [Abstract][Full Text] [Related]
27. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
28. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
[TBL] [Abstract][Full Text] [Related]
29. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
30. Modified constraint-induced therapy for children with hemiplegic cerebral palsy: a randomized trial.
Wallen M; Ziviani J; Naylor O; Evans R; Novak I; Herbert RD
Dev Med Child Neurol; 2011 Dec; 53(12):1091-9. PubMed ID: 21923854
[TBL] [Abstract][Full Text] [Related]
31. How do changes in body functions and structures, activity, and participation relate in children with cerebral palsy?
Wright FV; Rosenbaum PL; Goldsmith CH; Law M; Fehlings DL
Dev Med Child Neurol; 2008 Apr; 50(4):283-9. PubMed ID: 18312423
[TBL] [Abstract][Full Text] [Related]
32. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
33. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
34. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
Suputtitada A; Suwanwela NC
Disabil Rehabil; 2005 Feb; 27(4):176-84. PubMed ID: 15824048
[TBL] [Abstract][Full Text] [Related]
35. The short-term effects of combined modified constraint-induced movement therapy and botulinum toxin injection for children with spastic hemiplegic cerebral palsy.
Park ES; Rha DW; Lee JD; Yoo JK; Chang WH
Neuropediatrics; 2009 Dec; 40(6):269-74. PubMed ID: 20446220
[TBL] [Abstract][Full Text] [Related]
36. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
Ashford S; Turner-Stokes L
Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance.
Py AG; Zein Addeen G; Perrier Y; Carlier RY; Picard A
Ann Phys Rehabil Med; 2009 Apr; 52(3):215-23. PubMed ID: 19447084
[TBL] [Abstract][Full Text] [Related]
38. Effect of upper limb botulinum toxin-A therapy on health-related quality of life in children with hemiplegic cerebral palsy.
Redman TA; Finn JC; Bremner AP; Valentine J
J Paediatr Child Health; 2008; 44(7-8):409-14. PubMed ID: 18557810
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
40. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy.
Ackman JD; Russman BS; Thomas SS; Buckon CE; Sussman MD; Masso P; Sanders J; D'Astous J; Aiona MD;
Dev Med Child Neurol; 2005 Sep; 47(9):620-7. PubMed ID: 16138670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
